Oct 2026· Folia Microbiologica (Prague)· 0 citations· 69 references
Medicine
TL;DR
Today, owing to its targeted action, adequate tissue distribution and autodosing, phage therapy can serve as an ideal option for addressing hard-to-treat CNS infections caused by antibiotic resistant bacteria, despite of its challenging pharmacokinetics and formulation development.
Pseudomonas aeruginosa is one of the World Health Organization's (WHO) priority pathogens requiring urgent intervention because of its remarkable ability to develop antimicrobial resistance. The rapid emergence and global dissemination of multidrug-resistant P. aeruginosa have made the treatment of these infections inc...
Ahmed Elfadadny, W. Nageeb, Rokaia F. Ragab et al.· Biomedicine & pharmacotherap...· 0 citations
Pseudomonas aeruginosa is an opportunistic Gram-negative bacillus responsible for several infectious conditions, including ventilator-associated pneumonia, acute pneumonia, and chronic pulmonary infections. The emergence and spread of antibiotic-resistant strains represent a major public health concern, particularly in...
Bárbara Rafaela Ferreira Aio, Gustavo Aparecido da Cunha, L. C. Malaquias et al.· Microbiology Research· 0 citations
The bithiazole compound, MR335, effectively counteracted the synergistic interactions between respiratory viruses and S. aureus at concentration that retained antiviral but not antibacterial activity, suggesting their synergistic cooperation and opening the way to alternative therapies that prevent bacterial superinfec...
G. Radocchia, Marta De Angelis, Maria Grazia Martina et al.· Frontiers in Cellular and In...· 0 citations
Bacteriophage therapy offers a potential solution for treating multidrug-resistant Pseudomonas aeruginosa infections, especially those involving biofilms that reduce antibiotic effectiveness. However, successful in vitro results often don not lead to consistent clinical success due to various challenges. These challeng...
Qian-He Xu, Shao-Ping Liu, J. Xi· Frontiers in Microbiology· 0 citations
This review reframe phage therapy as a precision microbiome-modulating strategy for chronic pulmonary infections and discusses strategies that could support the development of safe, effective, and clinically applicable phage-based therapies for chronic pulmonary infections.
Ran Xiao, Yang Hao, Ya-Dong Gong et al.· Frontiers in Cellular and In...· 0 citations
Backgrounds:
Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter, better known as the ESKAPE group are gram-negative bacteria that are multi-drug resistant. Due to this, ESKAPE bacterial infections have become increasingly difficult to tr...
E. Engh, Angelica Rodriguez, Malaika Koreshi et al.· INNOVAPATH· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.